Table 1.
Patient characteristics (n=76).
| Characteristics | Number | Percentage (%) |
|---|---|---|
| Total | 76 | (100) |
| Age (years) | ||
| Median | 59 | |
| Range | 26 – 78 | |
| Gender | ||
| Female | 20 | (26) |
| Male | 56 | (74) |
| Performance Status (ECOG) | ||
| 0 | 18 | (24) |
| 1 | 45 | (59) |
| 2 | 13 | (17) |
| Histology | ||
| Adenocarcinoma | 76 | (100) |
| Grading | ||
| G1 | 1 | (1) |
| G2 | 18 | (24) |
| G3 | 45 | (59) |
| G4 | 9 | (12) |
| Not evaluable | 3 | (4) |
| UICC Stage | ||
| IV | 76 | (100) |
| Localisation of the primary tumor | ||
| AEG I | 14 | (18) |
| AEG II | 19 | (25) |
| AEG III | 1 | (1) |
| Corpus | 28 | (37) |
| Antrum | 13 | (17) |
| Unknown | 1 | (1) |
| Localisation of the metastases | ||
| Liver (HEP) | 30 | (39) |
| Lymph nodes (M1LYM) | 45 | (59) |
| Peritoneum (PER) | 34 | (45) |
| Lungs (PUL) | 9 | (12) |
| Skeleton (OS) | 6 | (8) |
| Ovary | 3 | (4) |
| Liver only | 7 | (9) |
ECOG – Eastern Cooperative Oncology Group; UICC – International Union Against Cancer.